Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders
Open Access
- 9 April 2017
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 6 (4), 45
- https://doi.org/10.3390/jcm6040045
Abstract
Along with haemophilia A and B, von Willebrand disease (VWD) and rare bleeding disorders (RBDs) cover all inherited bleeding disorders of coagulation. Bleeding tendency, which can range from extremely severe to mild, is the common symptom. VWD, due to a deficiency and/or abnormality of von Willebrand factor (VWF), represents the most frequent bleeding disorder, mostly inherited as an autosomal dominant trait. The diagnosis may be difficult, based on a bleeding history and different diagnostic assays, which evaluate the pleiotropic functions of VWF. Different treatment options are available for optimal management of bleeding and their prevention, and long-term outcomes are generally good. RBDs are autosomal recessive disorders caused by a deficiency of any other clotting factor, apart from factor XII, and cover roughly 5% of all bleeding disorders. The prevalence of the severe forms can range from 1 case in 500,000 up to 1 in 2–3 million, according to the defect. Diagnosis is based on bleeding history, coagulation screening tests and specific factor assays. A crucial problem in RBDs diagnosis is represented by the non-linear relationship between clinical bleeding severity and residual clotting levels; genetic diagnosis may help in understanding the phenotype. Replacement therapies are differently available for patients with RBDs, allowing the successful treatment of the vast majority of bleeding symptoms.Keywords
This publication has 90 references indexed in Scilit:
- Pathogen safety of long-term treatments for bleeding disorders: still relevant to current practiceHaematologica, 2013
- Parahemophilia: New Insights into Factor V DeficiencySeminars in Thrombosis and Hemostasis, 2013
- Congenital Fibrinogen Disorders: An UpdateSeminars in Thrombosis and Hemostasis, 2013
- Principles of care for the diagnosis and treatment of von Willebrand diseaseHaematologica, 2013
- Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)Haematologica, 2013
- VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESISMediterranean Journal of Hematology and Infectious Diseases, 2013
- The International Society on Thrombosis and Haematosis von Willebrand Disease Database: An UpdateSeminars in Thrombosis and Hemostasis, 2011
- von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding DisorderSeminars in Thrombosis and Hemostasis, 2011
- von Willebrand Disease: Local Diagnosis and Management of a Globally Distributed Bleeding DisorderSeminars in Thrombosis and Hemostasis, 2011
- Prevalence of von Willebrand disease in children: A multiethnic studyThe Journal of Pediatrics, 1993